European Review for Medical and Pharmacological Sciences-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=576840, encodeId=e07e5e68403a, content=这杂志自引这么高，没危险吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0e2492369, createdName=1247f785m03(暂无昵称), createdTime=Tue Sep 24 00:00:00 CST 2019, time=2019-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2195483, encodeId=ab86219548354, content=已经 on hold了，马上要被踢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b9215078520, createdName=145aa4a9m26暂无昵称, createdTime=Tue Mar 26 19:49:52 CST 2024, time=2024-03-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2102665, encodeId=4210210266517, content=请问有大佬分享一下这个杂志的endnote格式吗非常感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b406582144, createdName=ms7000001976046291, createdTime=Fri Nov 25 23:02:42 CST 2022, time=2022-11-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2138499, encodeId=6609213849977, content=偏重的研究方向：生信 经验分享：请问网络药理学没有实验验证的论文能接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e2f8354310, createdName=ms1000001665216280, createdTime=Tue May 23 02:55:44 CST 2023, time=2023-05-23, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2125887, encodeId=1ad0212588e97, content=为什么杂志官网能查到但是pubmed上搜不到呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLc3PoqaNe4QbttTiaiaGsyj0xJM11oKBl4lt5Hx9tgehd6oRWQ1dGibULlCSp3hvBiccQnT0NyR2aJxw/132, createdBy=063c108027, createdName=Daisy大林木, createdTime=Fri Apr 14 13:31:03 CST 2023, time=2023-04-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=589732, encodeId=c6b7589e32de, content=是的我09 2020-04-25 00:00:00 发表: 一直是under consideration吗 , beContent=我09 2020-04-25 00:00:00 发表: 一直是under consideration吗 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0e2492369, createdName=1247f785m03(暂无昵称), createdTime=Sun Apr 26 00:00:00 CST 2020, time=2020-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101613, encodeId=0887110161379, content=IF是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101614, encodeId=a99e110161453, content=选刊时需结合IF进行吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=859994, encodeId=fbe28599944b, content=审稿速度:1.0 经验分享：审稿很快，大概一周给了修改意见 对格式和语言要求严格 反复让修改了语言三次后直接接收 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b45a5414020, createdName=ms9406847301318168, createdTime=Wed Apr 29 11:07:57 CST 2020, time=2020-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801772, encodeId=60bc801e72cf, content=要被踢了，中国人扎堆投的，下场都比较惨, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7155340648, createdName=ms7000001982301907, createdTime=Wed Jul 08 21:07:46 CST 2020, time=2020-07-08, status=1, ipAttribution=)]

2019-09-24 1247f785m03(暂无昵称)

这杂志自引这么高，没危险吗？

103 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=576840, encodeId=e07e5e68403a, content=这杂志自引这么高，没危险吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0e2492369, createdName=1247f785m03(暂无昵称), createdTime=Tue Sep 24 00:00:00 CST 2019, time=2019-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2195483, encodeId=ab86219548354, content=已经 on hold了，马上要被踢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b9215078520, createdName=145aa4a9m26暂无昵称, createdTime=Tue Mar 26 19:49:52 CST 2024, time=2024-03-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2102665, encodeId=4210210266517, content=请问有大佬分享一下这个杂志的endnote格式吗非常感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b406582144, createdName=ms7000001976046291, createdTime=Fri Nov 25 23:02:42 CST 2022, time=2022-11-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2138499, encodeId=6609213849977, content=偏重的研究方向：生信 经验分享：请问网络药理学没有实验验证的论文能接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e2f8354310, createdName=ms1000001665216280, createdTime=Tue May 23 02:55:44 CST 2023, time=2023-05-23, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2125887, encodeId=1ad0212588e97, content=为什么杂志官网能查到但是pubmed上搜不到呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLc3PoqaNe4QbttTiaiaGsyj0xJM11oKBl4lt5Hx9tgehd6oRWQ1dGibULlCSp3hvBiccQnT0NyR2aJxw/132, createdBy=063c108027, createdName=Daisy大林木, createdTime=Fri Apr 14 13:31:03 CST 2023, time=2023-04-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=589732, encodeId=c6b7589e32de, content=是的我09 2020-04-25 00:00:00 发表: 一直是under consideration吗 , beContent=我09 2020-04-25 00:00:00 发表: 一直是under consideration吗 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0e2492369, createdName=1247f785m03(暂无昵称), createdTime=Sun Apr 26 00:00:00 CST 2020, time=2020-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101613, encodeId=0887110161379, content=IF是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101614, encodeId=a99e110161453, content=选刊时需结合IF进行吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=859994, encodeId=fbe28599944b, content=审稿速度:1.0 经验分享：审稿很快，大概一周给了修改意见 对格式和语言要求严格 反复让修改了语言三次后直接接收 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b45a5414020, createdName=ms9406847301318168, createdTime=Wed Apr 29 11:07:57 CST 2020, time=2020-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801772, encodeId=60bc801e72cf, content=要被踢了，中国人扎堆投的，下场都比较惨, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7155340648, createdName=ms7000001982301907, createdTime=Wed Jul 08 21:07:46 CST 2020, time=2020-07-08, status=1, ipAttribution=)]

2024-03-26 145aa4a9m26暂无昵称来自浙江省

已经 on hold了，马上要被踢了

24 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=576840, encodeId=e07e5e68403a, content=这杂志自引这么高，没危险吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0e2492369, createdName=1247f785m03(暂无昵称), createdTime=Tue Sep 24 00:00:00 CST 2019, time=2019-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2195483, encodeId=ab86219548354, content=已经 on hold了，马上要被踢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b9215078520, createdName=145aa4a9m26暂无昵称, createdTime=Tue Mar 26 19:49:52 CST 2024, time=2024-03-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2102665, encodeId=4210210266517, content=请问有大佬分享一下这个杂志的endnote格式吗非常感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b406582144, createdName=ms7000001976046291, createdTime=Fri Nov 25 23:02:42 CST 2022, time=2022-11-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2138499, encodeId=6609213849977, content=偏重的研究方向：生信 经验分享：请问网络药理学没有实验验证的论文能接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e2f8354310, createdName=ms1000001665216280, createdTime=Tue May 23 02:55:44 CST 2023, time=2023-05-23, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2125887, encodeId=1ad0212588e97, content=为什么杂志官网能查到但是pubmed上搜不到呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLc3PoqaNe4QbttTiaiaGsyj0xJM11oKBl4lt5Hx9tgehd6oRWQ1dGibULlCSp3hvBiccQnT0NyR2aJxw/132, createdBy=063c108027, createdName=Daisy大林木, createdTime=Fri Apr 14 13:31:03 CST 2023, time=2023-04-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=589732, encodeId=c6b7589e32de, content=是的我09 2020-04-25 00:00:00 发表: 一直是under consideration吗 , beContent=我09 2020-04-25 00:00:00 发表: 一直是under consideration吗 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0e2492369, createdName=1247f785m03(暂无昵称), createdTime=Sun Apr 26 00:00:00 CST 2020, time=2020-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101613, encodeId=0887110161379, content=IF是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101614, encodeId=a99e110161453, content=选刊时需结合IF进行吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=859994, encodeId=fbe28599944b, content=审稿速度:1.0 经验分享：审稿很快，大概一周给了修改意见 对格式和语言要求严格 反复让修改了语言三次后直接接收 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b45a5414020, createdName=ms9406847301318168, createdTime=Wed Apr 29 11:07:57 CST 2020, time=2020-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801772, encodeId=60bc801e72cf, content=要被踢了，中国人扎堆投的，下场都比较惨, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7155340648, createdName=ms7000001982301907, createdTime=Wed Jul 08 21:07:46 CST 2020, time=2020-07-08, status=1, ipAttribution=)]

2022-11-25 ms7000001976046291 来自上海

请问有大佬分享一下这个杂志的endnote格式吗非常感谢

0 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=576840, encodeId=e07e5e68403a, content=这杂志自引这么高，没危险吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0e2492369, createdName=1247f785m03(暂无昵称), createdTime=Tue Sep 24 00:00:00 CST 2019, time=2019-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2195483, encodeId=ab86219548354, content=已经 on hold了，马上要被踢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b9215078520, createdName=145aa4a9m26暂无昵称, createdTime=Tue Mar 26 19:49:52 CST 2024, time=2024-03-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2102665, encodeId=4210210266517, content=请问有大佬分享一下这个杂志的endnote格式吗非常感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b406582144, createdName=ms7000001976046291, createdTime=Fri Nov 25 23:02:42 CST 2022, time=2022-11-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2138499, encodeId=6609213849977, content=偏重的研究方向：生信 经验分享：请问网络药理学没有实验验证的论文能接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e2f8354310, createdName=ms1000001665216280, createdTime=Tue May 23 02:55:44 CST 2023, time=2023-05-23, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2125887, encodeId=1ad0212588e97, content=为什么杂志官网能查到但是pubmed上搜不到呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLc3PoqaNe4QbttTiaiaGsyj0xJM11oKBl4lt5Hx9tgehd6oRWQ1dGibULlCSp3hvBiccQnT0NyR2aJxw/132, createdBy=063c108027, createdName=Daisy大林木, createdTime=Fri Apr 14 13:31:03 CST 2023, time=2023-04-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=589732, encodeId=c6b7589e32de, content=是的我09 2020-04-25 00:00:00 发表: 一直是under consideration吗 , beContent=我09 2020-04-25 00:00:00 发表: 一直是under consideration吗 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0e2492369, createdName=1247f785m03(暂无昵称), createdTime=Sun Apr 26 00:00:00 CST 2020, time=2020-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101613, encodeId=0887110161379, content=IF是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101614, encodeId=a99e110161453, content=选刊时需结合IF进行吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=859994, encodeId=fbe28599944b, content=审稿速度:1.0 经验分享：审稿很快，大概一周给了修改意见 对格式和语言要求严格 反复让修改了语言三次后直接接收 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b45a5414020, createdName=ms9406847301318168, createdTime=Wed Apr 29 11:07:57 CST 2020, time=2020-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801772, encodeId=60bc801e72cf, content=要被踢了，中国人扎堆投的，下场都比较惨, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7155340648, createdName=ms7000001982301907, createdTime=Wed Jul 08 21:07:46 CST 2020, time=2020-07-08, status=1, ipAttribution=)]

2023-05-23 ms1000001665216280 来自吉林省

偏重的研究方向：生信
经验分享：请问网络药理学没有实验验证的论文能接收吗

1 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=576840, encodeId=e07e5e68403a, content=这杂志自引这么高，没危险吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0e2492369, createdName=1247f785m03(暂无昵称), createdTime=Tue Sep 24 00:00:00 CST 2019, time=2019-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2195483, encodeId=ab86219548354, content=已经 on hold了，马上要被踢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b9215078520, createdName=145aa4a9m26暂无昵称, createdTime=Tue Mar 26 19:49:52 CST 2024, time=2024-03-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2102665, encodeId=4210210266517, content=请问有大佬分享一下这个杂志的endnote格式吗非常感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b406582144, createdName=ms7000001976046291, createdTime=Fri Nov 25 23:02:42 CST 2022, time=2022-11-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2138499, encodeId=6609213849977, content=偏重的研究方向：生信 经验分享：请问网络药理学没有实验验证的论文能接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e2f8354310, createdName=ms1000001665216280, createdTime=Tue May 23 02:55:44 CST 2023, time=2023-05-23, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2125887, encodeId=1ad0212588e97, content=为什么杂志官网能查到但是pubmed上搜不到呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLc3PoqaNe4QbttTiaiaGsyj0xJM11oKBl4lt5Hx9tgehd6oRWQ1dGibULlCSp3hvBiccQnT0NyR2aJxw/132, createdBy=063c108027, createdName=Daisy大林木, createdTime=Fri Apr 14 13:31:03 CST 2023, time=2023-04-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=589732, encodeId=c6b7589e32de, content=是的我09 2020-04-25 00:00:00 发表: 一直是under consideration吗 , beContent=我09 2020-04-25 00:00:00 发表: 一直是under consideration吗 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0e2492369, createdName=1247f785m03(暂无昵称), createdTime=Sun Apr 26 00:00:00 CST 2020, time=2020-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101613, encodeId=0887110161379, content=IF是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101614, encodeId=a99e110161453, content=选刊时需结合IF进行吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=859994, encodeId=fbe28599944b, content=审稿速度:1.0 经验分享：审稿很快，大概一周给了修改意见 对格式和语言要求严格 反复让修改了语言三次后直接接收 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b45a5414020, createdName=ms9406847301318168, createdTime=Wed Apr 29 11:07:57 CST 2020, time=2020-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801772, encodeId=60bc801e72cf, content=要被踢了，中国人扎堆投的，下场都比较惨, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7155340648, createdName=ms7000001982301907, createdTime=Wed Jul 08 21:07:46 CST 2020, time=2020-07-08, status=1, ipAttribution=)]

2023-04-14 Daisy大林木来自山东省

为什么杂志官网能查到但是pubmed上搜不到呢

36 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=576840, encodeId=e07e5e68403a, content=这杂志自引这么高，没危险吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0e2492369, createdName=1247f785m03(暂无昵称), createdTime=Tue Sep 24 00:00:00 CST 2019, time=2019-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2195483, encodeId=ab86219548354, content=已经 on hold了，马上要被踢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b9215078520, createdName=145aa4a9m26暂无昵称, createdTime=Tue Mar 26 19:49:52 CST 2024, time=2024-03-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2102665, encodeId=4210210266517, content=请问有大佬分享一下这个杂志的endnote格式吗非常感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b406582144, createdName=ms7000001976046291, createdTime=Fri Nov 25 23:02:42 CST 2022, time=2022-11-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2138499, encodeId=6609213849977, content=偏重的研究方向：生信 经验分享：请问网络药理学没有实验验证的论文能接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e2f8354310, createdName=ms1000001665216280, createdTime=Tue May 23 02:55:44 CST 2023, time=2023-05-23, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2125887, encodeId=1ad0212588e97, content=为什么杂志官网能查到但是pubmed上搜不到呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLc3PoqaNe4QbttTiaiaGsyj0xJM11oKBl4lt5Hx9tgehd6oRWQ1dGibULlCSp3hvBiccQnT0NyR2aJxw/132, createdBy=063c108027, createdName=Daisy大林木, createdTime=Fri Apr 14 13:31:03 CST 2023, time=2023-04-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=589732, encodeId=c6b7589e32de, content=是的我09 2020-04-25 00:00:00 发表: 一直是under consideration吗 , beContent=我09 2020-04-25 00:00:00 发表: 一直是under consideration吗 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0e2492369, createdName=1247f785m03(暂无昵称), createdTime=Sun Apr 26 00:00:00 CST 2020, time=2020-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101613, encodeId=0887110161379, content=IF是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101614, encodeId=a99e110161453, content=选刊时需结合IF进行吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=859994, encodeId=fbe28599944b, content=审稿速度:1.0 经验分享：审稿很快，大概一周给了修改意见 对格式和语言要求严格 反复让修改了语言三次后直接接收 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b45a5414020, createdName=ms9406847301318168, createdTime=Wed Apr 29 11:07:57 CST 2020, time=2020-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801772, encodeId=60bc801e72cf, content=要被踢了，中国人扎堆投的，下场都比较惨, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7155340648, createdName=ms7000001982301907, createdTime=Wed Jul 08 21:07:46 CST 2020, time=2020-07-08, status=1, ipAttribution=)]

2020-04-26 1247f785m03(暂无昵称)

是的我09 2020-04-25 00:00:00 发表:
一直是under consideration吗

我09 2020-04-25 00:00:00 发表: 一直是under consideration吗

80 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=576840, encodeId=e07e5e68403a, content=这杂志自引这么高，没危险吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0e2492369, createdName=1247f785m03(暂无昵称), createdTime=Tue Sep 24 00:00:00 CST 2019, time=2019-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2195483, encodeId=ab86219548354, content=已经 on hold了，马上要被踢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b9215078520, createdName=145aa4a9m26暂无昵称, createdTime=Tue Mar 26 19:49:52 CST 2024, time=2024-03-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2102665, encodeId=4210210266517, content=请问有大佬分享一下这个杂志的endnote格式吗非常感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b406582144, createdName=ms7000001976046291, createdTime=Fri Nov 25 23:02:42 CST 2022, time=2022-11-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2138499, encodeId=6609213849977, content=偏重的研究方向：生信 经验分享：请问网络药理学没有实验验证的论文能接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e2f8354310, createdName=ms1000001665216280, createdTime=Tue May 23 02:55:44 CST 2023, time=2023-05-23, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2125887, encodeId=1ad0212588e97, content=为什么杂志官网能查到但是pubmed上搜不到呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLc3PoqaNe4QbttTiaiaGsyj0xJM11oKBl4lt5Hx9tgehd6oRWQ1dGibULlCSp3hvBiccQnT0NyR2aJxw/132, createdBy=063c108027, createdName=Daisy大林木, createdTime=Fri Apr 14 13:31:03 CST 2023, time=2023-04-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=589732, encodeId=c6b7589e32de, content=是的我09 2020-04-25 00:00:00 发表: 一直是under consideration吗 , beContent=我09 2020-04-25 00:00:00 发表: 一直是under consideration吗 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0e2492369, createdName=1247f785m03(暂无昵称), createdTime=Sun Apr 26 00:00:00 CST 2020, time=2020-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101613, encodeId=0887110161379, content=IF是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101614, encodeId=a99e110161453, content=选刊时需结合IF进行吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=859994, encodeId=fbe28599944b, content=审稿速度:1.0 经验分享：审稿很快，大概一周给了修改意见 对格式和语言要求严格 反复让修改了语言三次后直接接收 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b45a5414020, createdName=ms9406847301318168, createdTime=Wed Apr 29 11:07:57 CST 2020, time=2020-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801772, encodeId=60bc801e72cf, content=要被踢了，中国人扎堆投的，下场都比较惨, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7155340648, createdName=ms7000001982301907, createdTime=Wed Jul 08 21:07:46 CST 2020, time=2020-07-08, status=1, ipAttribution=)]

2021-12-27 衣谷

IF是什么？

0 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=576840, encodeId=e07e5e68403a, content=这杂志自引这么高，没危险吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0e2492369, createdName=1247f785m03(暂无昵称), createdTime=Tue Sep 24 00:00:00 CST 2019, time=2019-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2195483, encodeId=ab86219548354, content=已经 on hold了，马上要被踢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b9215078520, createdName=145aa4a9m26暂无昵称, createdTime=Tue Mar 26 19:49:52 CST 2024, time=2024-03-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2102665, encodeId=4210210266517, content=请问有大佬分享一下这个杂志的endnote格式吗非常感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b406582144, createdName=ms7000001976046291, createdTime=Fri Nov 25 23:02:42 CST 2022, time=2022-11-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2138499, encodeId=6609213849977, content=偏重的研究方向：生信 经验分享：请问网络药理学没有实验验证的论文能接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e2f8354310, createdName=ms1000001665216280, createdTime=Tue May 23 02:55:44 CST 2023, time=2023-05-23, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2125887, encodeId=1ad0212588e97, content=为什么杂志官网能查到但是pubmed上搜不到呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLc3PoqaNe4QbttTiaiaGsyj0xJM11oKBl4lt5Hx9tgehd6oRWQ1dGibULlCSp3hvBiccQnT0NyR2aJxw/132, createdBy=063c108027, createdName=Daisy大林木, createdTime=Fri Apr 14 13:31:03 CST 2023, time=2023-04-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=589732, encodeId=c6b7589e32de, content=是的我09 2020-04-25 00:00:00 发表: 一直是under consideration吗 , beContent=我09 2020-04-25 00:00:00 发表: 一直是under consideration吗 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0e2492369, createdName=1247f785m03(暂无昵称), createdTime=Sun Apr 26 00:00:00 CST 2020, time=2020-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101613, encodeId=0887110161379, content=IF是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101614, encodeId=a99e110161453, content=选刊时需结合IF进行吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=859994, encodeId=fbe28599944b, content=审稿速度:1.0 经验分享：审稿很快，大概一周给了修改意见 对格式和语言要求严格 反复让修改了语言三次后直接接收 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b45a5414020, createdName=ms9406847301318168, createdTime=Wed Apr 29 11:07:57 CST 2020, time=2020-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801772, encodeId=60bc801e72cf, content=要被踢了，中国人扎堆投的，下场都比较惨, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7155340648, createdName=ms7000001982301907, createdTime=Wed Jul 08 21:07:46 CST 2020, time=2020-07-08, status=1, ipAttribution=)]

2021-12-28 乌云背后的幸福线

选刊时需结合IF进行吗？

48 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=576840, encodeId=e07e5e68403a, content=这杂志自引这么高，没危险吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0e2492369, createdName=1247f785m03(暂无昵称), createdTime=Tue Sep 24 00:00:00 CST 2019, time=2019-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2195483, encodeId=ab86219548354, content=已经 on hold了，马上要被踢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b9215078520, createdName=145aa4a9m26暂无昵称, createdTime=Tue Mar 26 19:49:52 CST 2024, time=2024-03-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2102665, encodeId=4210210266517, content=请问有大佬分享一下这个杂志的endnote格式吗非常感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b406582144, createdName=ms7000001976046291, createdTime=Fri Nov 25 23:02:42 CST 2022, time=2022-11-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2138499, encodeId=6609213849977, content=偏重的研究方向：生信 经验分享：请问网络药理学没有实验验证的论文能接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e2f8354310, createdName=ms1000001665216280, createdTime=Tue May 23 02:55:44 CST 2023, time=2023-05-23, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2125887, encodeId=1ad0212588e97, content=为什么杂志官网能查到但是pubmed上搜不到呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLc3PoqaNe4QbttTiaiaGsyj0xJM11oKBl4lt5Hx9tgehd6oRWQ1dGibULlCSp3hvBiccQnT0NyR2aJxw/132, createdBy=063c108027, createdName=Daisy大林木, createdTime=Fri Apr 14 13:31:03 CST 2023, time=2023-04-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=589732, encodeId=c6b7589e32de, content=是的我09 2020-04-25 00:00:00 发表: 一直是under consideration吗 , beContent=我09 2020-04-25 00:00:00 发表: 一直是under consideration吗 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0e2492369, createdName=1247f785m03(暂无昵称), createdTime=Sun Apr 26 00:00:00 CST 2020, time=2020-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101613, encodeId=0887110161379, content=IF是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101614, encodeId=a99e110161453, content=选刊时需结合IF进行吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=859994, encodeId=fbe28599944b, content=审稿速度:1.0 经验分享：审稿很快，大概一周给了修改意见 对格式和语言要求严格 反复让修改了语言三次后直接接收 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b45a5414020, createdName=ms9406847301318168, createdTime=Wed Apr 29 11:07:57 CST 2020, time=2020-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801772, encodeId=60bc801e72cf, content=要被踢了，中国人扎堆投的，下场都比较惨, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7155340648, createdName=ms7000001982301907, createdTime=Wed Jul 08 21:07:46 CST 2020, time=2020-07-08, status=1, ipAttribution=)]

2020-04-29 ms9406847301318168

审稿速度:1.0
经验分享：审稿很快，大概一周给了修改意见
对格式和语言要求严格
反复让修改了语言三次后直接接收

116 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=576840, encodeId=e07e5e68403a, content=这杂志自引这么高，没危险吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0e2492369, createdName=1247f785m03(暂无昵称), createdTime=Tue Sep 24 00:00:00 CST 2019, time=2019-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2195483, encodeId=ab86219548354, content=已经 on hold了，马上要被踢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b9215078520, createdName=145aa4a9m26暂无昵称, createdTime=Tue Mar 26 19:49:52 CST 2024, time=2024-03-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2102665, encodeId=4210210266517, content=请问有大佬分享一下这个杂志的endnote格式吗非常感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b406582144, createdName=ms7000001976046291, createdTime=Fri Nov 25 23:02:42 CST 2022, time=2022-11-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2138499, encodeId=6609213849977, content=偏重的研究方向：生信 经验分享：请问网络药理学没有实验验证的论文能接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e2f8354310, createdName=ms1000001665216280, createdTime=Tue May 23 02:55:44 CST 2023, time=2023-05-23, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2125887, encodeId=1ad0212588e97, content=为什么杂志官网能查到但是pubmed上搜不到呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLc3PoqaNe4QbttTiaiaGsyj0xJM11oKBl4lt5Hx9tgehd6oRWQ1dGibULlCSp3hvBiccQnT0NyR2aJxw/132, createdBy=063c108027, createdName=Daisy大林木, createdTime=Fri Apr 14 13:31:03 CST 2023, time=2023-04-14, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=589732, encodeId=c6b7589e32de, content=是的我09 2020-04-25 00:00:00 发表: 一直是under consideration吗 , beContent=我09 2020-04-25 00:00:00 发表: 一直是under consideration吗 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0e2492369, createdName=1247f785m03(暂无昵称), createdTime=Sun Apr 26 00:00:00 CST 2020, time=2020-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101613, encodeId=0887110161379, content=IF是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101614, encodeId=a99e110161453, content=选刊时需结合IF进行吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=859994, encodeId=fbe28599944b, content=审稿速度:1.0 经验分享：审稿很快，大概一周给了修改意见 对格式和语言要求严格 反复让修改了语言三次后直接接收 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b45a5414020, createdName=ms9406847301318168, createdTime=Wed Apr 29 11:07:57 CST 2020, time=2020-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801772, encodeId=60bc801e72cf, content=要被踢了，中国人扎堆投的，下场都比较惨, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7155340648, createdName=ms7000001982301907, createdTime=Wed Jul 08 21:07:46 CST 2020, time=2020-07-08, status=1, ipAttribution=)]

2020-07-08 ms7000001982301907

要被踢了，中国人扎堆投的，下场都比较惨

88 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务